NG has had a rough week, and the story is less about short sellers than about a pre-production gold developer falling harder than its peers in a sector-wide pullback.
The stock shed 11.5% over the past five sessions to close at CAD 10.28, with a further 4.1% drop on Tuesday alone. That underperformance is the week's most interesting tension. Gold miners broadly sold off, but NG's slide was steeper than most. Close peer PPTA fell 12%, and EQX and SKE both dropped around 14%. Meanwhile, more diversified producers like AEM and WPM gave back roughly 8-9%. NovaGold's declines are clustering with the weakest corner of the peer group — the names without near-term cash flow.
The lending market offers no particular drama here. Short interest is a modest 1.6% of free float — low by any standard — and has drifted up only gradually, rising about 5% over the week and 8% over the past month to roughly 6.5 million shares. That's a slow build, not an aggressive short thesis. Borrowing costs reflect that calm: the cost to borrow has actually eased, running at 0.47% after sitting closer to 0.52-0.53% earlier in the month. Availability is genuinely loose at over 1,380% — meaning for every share currently borrowed, there are nearly fourteen more available in the lending pool. Nothing in the borrow market signals squeeze pressure or unusual conviction from the short side.
The fundamental tension for NovaGold is structural, not technical. The company remains a pre-production developer anchored to the Donlin Gold project in Alaska, a long-dated, capital-intensive asset. The price-to-book multiple has expanded to around 11.6x — striking for a company with negative earnings, negative ROA, and negative EV/EBITDA. That valuation reflects optionality on gold prices rather than any near-term cash flow. The ORTEX short score is a benign 32.7, roughly mid-range and barely moving, consistent with a name where shorts are present but not pressing. Factor scores are similarly unremarkable: EPS surprise ranks near the bottom at the 28th percentile, reflecting a company with no earnings to beat. The one relative bright spot is dividend score at the 66th percentile, though NovaGold pays no dividend — that reading likely reflects the absence of any dividend cut risk rather than any income quality.
The ownership base tells its own story. The Electrum Group sits at 21% of shares outstanding with no reported change in the latest filing, anchoring the register. Paulson & Co holds 6.2%, also unchanged. Lingotto Investment Management and FMR (Fidelity) both added shares in the most recent reporting period, with Lingotto adding roughly 1.6 million shares and FMR adding nearly 1.5 million as of late May. Amundi added two million shares as of the end of March. That's a group of long-duration holders buying into the thesis — but their last reported dates predate the recent slide, and the most recent earnings event on June 22nd was accompanied by a single-day drop of 7.8%, suggesting whatever news came with that release was not received warmly.
With no next earnings date currently scheduled and the stock now down roughly 4% over the past month, the setup heading into summer is one where direction will likely track gold prices and any Donlin project updates more closely than the short-side positioning.
See the live data behind this article on ORTEX.
Open NG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
